MedPath

A study to assess the transfusion of leukoreduced blood units in thalassemia patients.

Not Applicable
Completed
Conditions
Health Condition 1: D561- Beta thalassemia
Registration Number
CTRI/2022/04/042168
Lead Sponsor
PGIMER Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1. Adults

2. Transfusion-dependent thalassemia major patients

3. Receiving transfusions exclusively at the PGIMER, Chandigarh

Exclusion Criteria

1. Minors (age <18 yrs)

2. Red cell autoantibodies in the patient

3. Massive splenomegaly

4. Any bleeding episode in the last 24 hours

5. Transfusion of any other blood product during the same episode

6. Pregnancy

7. Patients receiving washed red blood cells

8. Active ongoing fever or documented infection

9. Increased annual blood transfusion requirement ( >200-220 mL/kg/year)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath